Old Web
English
Sign In
Acemap
>
Paper
>
1611PDA phase II, multicenter study of the EZH2 inhibitor tazemetostat in adults (INI1-negative tumors cohort) (NCT02601950)
1611PDA phase II, multicenter study of the EZH2 inhibitor tazemetostat in adults (INI1-negative tumors cohort) (NCT02601950)
2018
Silvia Stacchiotti
J-Y. Blay
Robin L. Jones
G D D Demetri
Olivier Mir
A. Italiano
David Thomas
T W-W Chen
Patrick Schöffski
Thierry Gil
Thierry Jahan
Gregory M. Cote
Ravin Ratan
Steven Attia
Maria Roche
Scott R. Daigle
I. Sapir
Alicia Clawson
Mrinal M. Gounder
Keywords:
Cohort
General surgery
Tazemetostat
EZH2
Medicine
Internal medicine
multicenter study
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
4
Citations
NaN
KQI
[]